Seminars in Oncology Nursing最新文献

Study aim: The aim of the study is to explore how nurses document the nursing processes within a cancer care setting using digital health record (DHR).

Research question: How do nurses document the nursing processes within a cancer care setting using DHR?

Study design: A cross-sectional study.

Methodology: Twenty clinical care records were randomly selected from a large metropolitan hospital in a single medical oncology inpatient ward in Australia. The audit was conducted using the D-Catch instrument to assess the completeness and quality of nursing record using the five elements of the nursing process. Data analysis was conducted in IBM SPSS Statistics version 29.

Findings: The findings from the study showed evidence of high scores across all aspects of the nursing process, both in the completeness of record and an overall positive outcome for the quality of nursing documentation. However, documentation relating to assessment of patients' holistic care needs showed low to zero evidence of any documented record.

Implications on care: This study provided important insight into the documentation of the nursing processes within DHR. The concerns around limited documentation in capturing holistic care needs require attention. The application of D-Catch tool in assessing the nursing process remains useful, as shown in this study; however, its usability within a digital context needs further investigation.

Background: Nipple-areola complex (NAC) tattooing is an increasingly important component of breast reconstruction after mastectomy, supporting both aesthetic restoration and psychosocial recovery. However, NAC tattooing practices remain heterogeneous, with limited evidence on standardized protocols, nursing roles, and patient-reported outcomes.

Objective: This scoping review aimed to examine the clinical, psychosocial, professional, and organizational aspects of NAC tattooing in post-mastectomy care.

Methods: Following Joanna Briggs Institute and PRISMA-ScR guidelines, we systematically searched PubMed, Scopus, CINAHL, and EMBASE, supplemented by grey literature. Eligible studies addressed NAC medical tattooing for women undergoing breast reconstruction in any clinical setting. Data were extracted on study characteristics, professional roles, care models, psychosocial outcomes, and use of validated assessment tools. Computational analyses, including topic modeling, sentiment analysis, and multiple correspondence analysis, were conducted to identify thematic clusters and geographic patterns.

Results: Sixty-nine studies met inclusion criteria. The literature predominantly emphasized technical and aesthetic aspects, with minimal standardization in psychosocial assessment. Nurses were primarily associated with patient support, counseling, and nurse-led services, while surgeons were linked to procedural roles. Marked geographic and organizational variability emerged, with inconsistent reimbursement practices and few economic evaluations. Validated patient-reported outcome measures, such as the BREAST-Q, were rarely employed.

Conclusions: NAC tattooing is a promising, minimally invasive intervention within survivorship care. To optimize patient-centred outcomes and equitable access, future efforts should focus on standardizing protocols, implementing validated psychosocial assessments, and expanding nurse-led integrative care models.

Objectives: This review aims to bridge genomic insights with oncology nursing practice, promoting risk-informed care for patients with hereditary breast cancer (HBC).

Methods: This study reviewed publications from 2018 to 2024, searching PubMed, CINAHL, and Cochrane under PRISMA guidelines. It systematically reviews GI, emphasizing sporadic and hereditary breast cancer (BC), including BRCA1/2-related hereditary breast and ovarian cancer syndrome (HBOC), Li-Fraumeni syndrome (TP53 mutations), and Lynch syndrome (MSI-driven BC).

Results: Key genomic alterations such as TP53, BRCA1/2, and BCL2 mutations were found across various BC subtypes, including triple-negative, HER2-positive, and hormone receptor-positive tumors. Given the hereditary nature of some BC cases, genetic testing is crucial for risk assessment and early intervention, particularly as part of personalized screening protocols. Inhibiting these pathways with BCL2 inhibitors, PARP inhibitors for BRCA-mutated tumors, and immune checkpoint inhibitors for MSI-high tumors represents a promising therapeutic strategy.

Conclusions: This review highlights the importance of integrating genomic findings into personalized care planning, genetic counseling, and patient education.

Implications for nursing practice: Oncology nurses play a central role in applying genomic knowledge in patient care. They support informed decision-making regarding genetic testing, encourage adherence to surveillance protocols, monitor patients on targeted therapies, and advocate for equitable access to genetic services.

Objective: To map the professional roles of nurses in genetic counseling (GC) for hereditary neoplastic syndromes (HNS).

Methods: A scoping review was conducted following the JBI methodological framework. The search involved three stages-strategy validation, database querying, and reference tracking-and included SCOPUS, Medline via PubMed, CINAHL, and Web of Science, between March and April 2024.

Results: From 1,089 identified records, 18 studies met the inclusion criteria. Most were conducted in the United States (12/66.6%). The roles of nurses in GC included risk assessment, pre- and post-test counseling, and patient follow-up. Fewer studies reported nurse-led coordination of GC services, reflecting a gap in leadership and institutional autonomy. The scope of practice varied depending on professional training, national regulations, and local protocols.

Conclusion: This scoping review substantiates nurses' central role in GC for HNS. However, their autonomy is constrained by policies and inequities. Enhanced education and standardized nurse-led protocols can strengthen GC, reduce disparities, and expedite prevention.

Implications for nursing practice: To meet the rising demand for oncology genetic services, policymakers should fund nurse education and training, clarify professional roles, and expand nurses' decision-making autonomy in GC. Scaling nurse-led, standardized risk-assessment and screening-particularly in primary care and underserved settings-can accelerate preventive access. Establishing nurse-led regional networks will improve equity, reduce disparities, and align cancer genetics services with local health-system contexts by addressing structural barriers.